Search Keywords
Financial Times Wall Street Journal Economist
News Period From   To
News: 60885    Funds: $437    Pays: $524

Go Back to
News List
|
|
This News on
Daily Paywall
  Rated 168 | Views 448
Rate it | Share it 

Business
Novartis Gets European Approval For Glaucoma Treatment
From the Wall Street Journal of Tue, 23 Dec 2014 02:26:37 EST
Novartis’s eye-care unit received European approval for the use of a glaucoma eye drop in juvenile patients.
Novartis’s eye-care unit received European approval for the use of a glaucoma eye drop in juvenile patients. Associated Press

ZURICH— Novartis AG said Tuesday that its eye-care unit received European approval for the use of a glaucoma eye drop in juvenile patients.

Basel-based Novartis said the European Commission granted an additional indication for its Travatan treatment, which is presently used for adult patients with glaucoma. The treatment, made by the company’s Alcon eye-care unit, can now be used in patients under the age of 18 years.

The approval follows a Phase III study, or final stage of human testing, that showed the drug to be safe and effective for treating children between the ages of two months and less than 18 years even when using adult dosage.

Glaucoma is a progressive eye disease that affects the optic nerve and leads to a gradual loss of vision and eventually blindness if left untreated. The loss of vision is irreversible and the disease affects more than 60 million people world-wide.

Alcon, which also makes contact lenses to ophthalmic surgical products, is one of three Novartis units that generate the bulk of its revenue.

Write to Neil MacLucas at neil.maclucas@wsj.com



This article is provided by DailyPaywall.com, which is published and distributed by Paolo Cirio Ltd., registered in England, number 8188080. Registered Office: Suite 36, 88-90 Hatton Garden, City of London, EC1 N8PG, United Kingdom. Paolo Cirio Ltd. alone is responsible and liable for information and services provided through Daily Paywall’s newspaper and website.

The most relevant news can also help with your daily little expenses!




Earn Money
Offer Money
Buy Advertising
Buy Artwork Article

Similar Articles